Trials / Completed
CompletedNCT03008785
Effect of Isoflavone Supplementation Associated With Physical Exercise in the Health Parameters of Postmenopausal Women
Effect of Isoflavone Supplementation Associated With Physical Exercise on Blood Pressure, Lipic and Inflamatory Profile, Body Composition and Hydratation and Climacteric Symptoms in Postmenopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Federal University of Uberlandia · Academic / Other
- Sex
- Female
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study evaluate if 10 weeks of mixed exercise combined with isoflavones could have greater effects on climacteric symptoms, body composition and hydratation, lipidic and inflamatory profile than exercise alone in postmenopausal women. the participants will be randomly assigned to the group: placebo and exercise or 100mg of isoflavone and exercise.
Detailed description
Several endocrine metabolic changes occur during the climacteric period, due to the lack of estrogen and also by the aging process and some studies show that ingestion of isoflavones by postmenopausal women may have benefits. Theoretically the isoflavone potentiate the effects obtained during exercise
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | exercise | The training program consisted of aerobic and resisted combined physical exercises performed during 10 weeks, three times weekly with 45 minutes sessions: 5 minutes of warm-up on treadmill, 20 minutes of aerobic exercises and 20 minutes of resistance exercises. |
| OTHER | isoflavone | Daily supplementation in 1 capsule per day of 100mg of isoflavones (containing 3.3% genistein, 93.5% dadzein and 3.2% glycitein). |
| OTHER | Placebo | Daily supplementation in 1 capsule per day containing starch of corn. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-07-01
- Completion
- 2016-12-01
- First posted
- 2017-01-02
- Last updated
- 2019-02-20
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03008785. Inclusion in this directory is not an endorsement.